KING LUTHER CAPITAL MANAGEMENT CORP 13D and 13G filings for scPharmaceuticals Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-10-08 5:02 pm Sale | 2025-09-30 | 13G | scPharmaceuticals Inc. SCPH | KING LUTHER CAPITAL MANAGEMENT CORP | 2,128,391 4.000% | -1,540,779 (-41.99%) | Filing |
| 2025-07-21 4:01 pm Purchase | 2025-06-30 | 13G | scPharmaceuticals Inc. SCPH | KING LUTHER CAPITAL MANAGEMENT CORP | 3,669,170 7.000% | 420,000 (+12.93%) | Filing |
| 2025-04-28 4:01 pm Purchase | 2025-03-31 | 13G | scPharmaceuticals Inc. SCPH | KING LUTHER CAPITAL MANAGEMENT CORP | 3,249,170 6.500% | 268,760 (+9.02%) | Filing |
| 2025-01-28 10:56 am Purchase | 2024-12-31 | 13G | scPharmaceuticals Inc. SCPH | KING LUTHER CAPITAL MANAGEMENT CORP | 2,980,410 6.000% | 95,730 (+3.32%) | Filing |
| 2024-11-15 4:06 pm Purchase | 2024-11-14 | 13G | scPharmaceuticals Inc. SCPH | KING LUTHER CAPITAL MANAGEMENT CORP | 2,884,680 5.800% | 561,390 (+24.16%) | Filing |
| 2024-10-30 4:05 pm Purchase | 2024-09-30 | 13G | scPharmaceuticals Inc. SCPH | KING LUTHER CAPITAL MANAGEMENT CORP | 2,323,290 4.600% | 22,400 (+0.97%) | Filing |
| 2024-07-02 4:06 pm Purchase | 2024-06-30 | 13G | scPharmaceuticals Inc. SCPH | KING LUTHER CAPITAL MANAGEMENT CORP | 2,300,890 6.400% | 404,301 (+21.32%) | Filing |
| 2024-05-20 4:05 pm Purchase | 2024-05-17 | 13G | scPharmaceuticals Inc. SCPH | KING LUTHER CAPITAL MANAGEMENT CORP | 1,896,589 5.300% | 1,896,589 (New Position) | Filing |